Regeneron Ventures
Overview
Regeneron Ventures is a corporate venture capital fund established in April 2024, focusing on investing in early-stage biotechnology and health technology companies. Operating independently from its sole limited partner, Regeneron Pharmaceuticals, Inc., the fund shares a patient-centric, science-based mission, principles, and values. Its investment mandate encompasses healthcare broadly, with a particular emphasis on biotechnology, medical devices, tools, and enabling technologies. Investment decisions are based on the quality of the people, science, and data, favoring breakthrough innovations and tolerating risk and uncertainty. The fund aims to help portfolio companies transform great ideas into impactful products for patients, driving investment results through this mission. The general partner is independently managed by former Regeneron executives Jay S. Markowitz, M.D., and Michael Aberman, M.D., who lead the fund's investment strategy. Regeneron Pharmaceuticals, Inc. is the fund's exclusive limited partner, committing $100 million annually for five years.
Investment Focus
- Focus on biotechnology, medical devices, tools, and enabling technologies
- Preference for breakthrough innovations
- Tolerance for risk and uncertainty
- Alignment with patient-centric, science-based mission
Get the full list of 54,000+ investors
Regeneron Ventures and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Regeneron Ventures
What sectors does Regeneron Ventures invest in?
Regeneron Ventures invests in Pharmaceuticals, Medical Devices, Biotechnology and Health Technology, and is based in Connecticut, United States. Regeneron Ventures is listed as a corporate vc in the ConnectSafely investor database.
What stage does Regeneron Ventures invest at?
Regeneron Ventures backs companies at Seed, Early Stage and Growth.
Which regions does Regeneron Ventures invest in?
Regeneron Ventures invests across United States.
Last updated · Source: ConnectSafely investor database